Technology to select candidates for prophylactic treatments to prevent sporadic breast cancers
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44CA206774
- Recipient
-
Silbiotech Inc. UEI ELPEMYKNMLW4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,575,641
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Montgomery Village, MD 20879, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $50,751 | |
| Amendment | $566,597 | |
| Original award | $958,293 |
Quick answers
Who received award R44CA206774?
R44CA206774 was awarded to Silbiotech Inc. by National Cancer Institute (National Institutes of Health) on July 8, 2016.
How much is award R44CA206774 worth?
$1,575,641 has been obligated on R44CA206774.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award